|
LXEO Lexeo Therapeutics Inc 1907108 |
| Balance Sheet |
|
Current Assets
|
159,458,000 |
|
Assets
|
173,865,000 |
|
Current Liabilities
|
26,818,000 |
|
Liabilities
|
34,539,000 |
|
Equity
|
139,326,000 |
|
Shares Out
|
33,061,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-52,825,000 |
|
Investing Cash Flow
|
-494,000 |
| Market Analysis |
Market Cap
|
354,413,928 |
|
Price
|
5.07 |
|
BVPS
|
4.21 |
|
PB
|
1.19 |
|
EPS
|
-2.81 |
|
PS
|
6.91 |
|
FCF
|
-53,319,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXEO documents filed with the SEC.
LXEO Filings
Clear
